Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Description

To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.

Conditions

Peripheral Nerve Stimulation, Chemotherapy-induced Peripheral Neuropathy

Talk to us

Study Overview

On this page

Study Details

Study overview

To learn if peripheral nerve stimulation (PNS) can help to improve pain in participants with CIPN.

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Condition
Peripheral Nerve Stimulation
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Participants diagnosed with chronic (≥90 days duration) CIPN (due to either vinca alkaloids, taxanes, bortezomib, thalidomide, platinum-based compounds or ionizing irradiation) of the lower extremity, seen at Pain Management Center at MD Anderson Cancer Center
  • * Participants reports baseline pain ≥ 4 (0-10 scale, NRS)
  • * Participants between ages 18-85 years old
  • * Participants who have completed chemotherapy within the previous year at the time of enrollment
  • * Participants with cognitive dysfunction
  • * Participants with recent history (\<6 months) of drug or alcohol abuse
  • * Participants with open skin lesion or undergoing antibiotic therapy for local for systemic infection
  • * Participants with allergies to local anesthesia, steroids, or adhesives
  • * Pregnant participants
  • * Participants with conditions that conflict with the SPRINT PNS System Indications for Use, including Contraindications and Warnings.

Ages Eligible for Study

18 Years to 85 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Saba Javed, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2024-12-31